TPG BIOTECH
TPG Biotech is part of the growth equity and venture investment platform of TPG, the global private investment firm. TPG Biotech targets investments in pharmaceutical discovery and development, medical technology, diagnostics, healthcare and pharmaceutical services, life sciences, as well as industrial applications of biotechnology. TPG Biotech has access to the broader resources of TPG.
TPG BIOTECH
Social Links:
Industry:
Biotechnology Finance Venture Capital
Founded:
2002-06-01
Status:
Active
Contact:
+1 415 743 1500
Email Addresses:
[email protected]
Technology used in webpage:
Google Font API Google Maps Amazon GStatic Google Static Content Google Maps API Amazon S3 CDN Amazon Oregon Region Proofpoint UltraDNS Neustar
Similar Organizations
Citdex
Citdex is a global multi-strategy applied venture Investment firm inexorably focused on innovative technologies and funds.
Correlation Ventures
Correlation Ventures finances early, seed, and later stage venture, and debt financing investments and is based in California.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-21 | Carisma Therapeutics | TPG Biotech investment in Series C - Carisma Therapeutics | 30 M USD |
| 2021-03-01 | Carisma Therapeutics | TPG Biotech investment in Series B - Carisma Therapeutics | 12 M USD |
| 2021-01-07 | Carisma Therapeutics | TPG Biotech investment in Series B - Carisma Therapeutics | 47 M USD |
| 2020-10-22 | Azura Ophthalmics | TPG Biotech investment in Series C - Azura Ophthalmics | 20 M USD |
| 2020-06-09 | DNAnexus | TPG Biotech investment in Series G - DNAnexus | 100 M USD |
| 2020-04-27 | Avalyn Pharma | TPG Biotech investment in Series B - Avalyn Pharma | 35.5 M USD |
| 2019-04-24 | Satsuma Pharmaceuticals | TPG Biotech investment in Series B - Satsuma Pharmaceuticals | 62 M USD |
| 2019-04-01 | Fusion Pharmaceuticals | TPG Biotech investment in Series B - Fusion Pharmaceuticals | 105 M USD |
| 2019-02-06 | DNAnexus | TPG Biotech investment in Series F - DNAnexus | 68 M USD |
| 2019-01-01 | Trevi Therapeutics | TPG Biotech investment in Series C - Trevi Therapeutics | 10 M USD |
More informations about "TPG Biotech"
TPG Biotech - Crunchbase Investor Profile & Investments
TPG Biotech is part of the growth equity and venture investment platform of TPG, the global private investment firm. TPG Biotech targets investments in pharmaceutical discovery and …See details»
Leaders in Healthcare Investing | TPG Capital Healthcare
The TPG Capital Healthcare team has a long history of partnering with management teams delivering long-term value to the healthcare system. ... Provider of integrated …See details»
Who We Are | Meet our Team | TPG - TPG Inc.
TPG’s leadership team is made up of world-class executives and business leaders who have an average of 27 years of professional experienceSee details»
TPG Biotech - Investments, Portfolio & Company Exits - Crunchbase
TPG Biotech 's most notable exits include Carisma Therapeutics, Unchained Labs, and Fusion Pharmaceuticals. Which industries has this organization had the most exits in? Show . …See details»
Meet TPG | A Leading Global Alternative Asset Manager
Through TPG’s family office roots, entrepreneurial heritage, and West Coast base, we have developed a differentiated approach to alternative investments based on innovation, organic growth, and a culture of openness and …See details»
TPG tops up funds to $580M for investments across life …
Aug 6, 2024 Asset manager TPG, which has supported biotechs such as Sionna Therapeutics and Santa Ana Bio, has topped up its Life Science Innovations fund, bringing total capital raised for the effort to $580 ...See details»
List of top TPG Biotech Portfolio Companies - Crunchbase
Jan 20, 2007 TPG Biotech is a growth-stage equity and venture investment platform focused on the biotechnology industry. This list of organizations invested in by TPG Biotech provides data …See details»
Carolyn Ng - TPG Life Sciences Innovation | Biotech Showcase …
Biotech Showcase™, the investor conference in San Francisco produced by Demy-Colton and EBD Group, is devoted to providing private and public biotechnology and life sciences …See details»
K2 Medical Research and TPG Establish Partnership to Build a …
SAN FRANCISCO & ORLANDO, Fla.--(BUSINESS WIRE)--Jun. 17, 2024-- TPG (NASDAQ: TPG), a leading global alternative asset management firm, today announced a significant …See details»
BioCentury - With an eye toward ‘inflection capital’ for biotechs, …
Aug 6, 2024 After about four years of stress testing its life sciences strategy, TPG is committing itself to the sector with $580 million in total committed capital to invest, including the close of …See details»
TPG to Acquire Leading Specialty Healthcare IT Platform Nextech
TPG (NASDAQ: TPG) is a leading global alternative asset management firm, founded in San Francisco in 1992, with $137 billion of assets under management and investment and …See details»
MBrace Therapeutics Raises $85 Million Series B Financing to
Nov 14, 2023 Oversubscribed Series B round led by TPG includes prominent group of new and existing investors, bringing total raised to-date to over $110 million. Funding supports rapid …See details»
TPG Biotech - Funding, Financials, Valuation & Investors
TPG Biotech has raised a total of $60M in a single venture fund, TPG Biotechnology Partners V. This fund was announced on Jun 20, 2016 and raised a total of . obfuscated. obfuscated. …See details»
Biopharma: Strong Activity in the Face of Regulatory and Pricing ...
Apr 17, 2019 The division will focus on providing capital to underfunded biopharma programs to develop and commercialize new drugs. TPG established TPG Biotech, a venture capital fund …See details»
Heather Preston - Managing Partner - Crunchbase
Heather Preston has served on Otonomy’s board of directors since August 2010. Heather Preston is currently employed as a partner and managing director of TPG Biotech, a biotechnology …See details»
TPG Biotech - Contacts, Employees, Board Members, Advisors
TPG Biotech has 6 current employee profiles, including Co-Founder Kelvin L. Davis. Kelvin L. Davis Co-Founder. Kevin R. Lind Lead Underwriter. William S. Price Co-Founder. Jeffrey A …See details»
Eran Nadav - Managing Director @ TPG Biotech - Crunchbase
Dr. Nadav joined TPG Biotechnology in 2007 with a focus on global pharmaceuticals and biotechnology investments. Prior to this, Dr. Nadav served as Business Development Director …See details»
K2 Medical Research and TPG Establish Partnership to Build a …
Jun 17, 2024 SAN FRANCISCO & ORLANDO – June 17, 2024 – TPG (NASDAQ: TPG), a leading global alternative asset management firm, today announced a significant strategic …See details»
TPG Healthcare - 2023 Year End Update | TPG - TPG Inc.
Jan 29, 2024 Remind Me: TPG closed its previously announced acquisition of Nextech, a leading provider of electronic medical record (EMR) and practice management solutions to …See details»